Ringer's Solution and Ceftriaxone Injection: Interaction Details
AI-assisted, pharmacist-reviewed · Source data updated Aug 8, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Ceftriaxone Injection
Ringer's Solution
No brand names on record
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
What happens
An increased risk of cefTRIAXone-calcium precipitates
Interaction Deep Dive
Due to the risk of the precipitation of cefTRIAXone-calcium salt, the concurrent use of IV cefTRIAXone sodium and calcium-containing IV solutions, including continuous calcium-containing infusions such as parenteral nutrition, in neonates (28 days old or less) is contraindicated1. European postmarketing reports have documented the deaths of 6 infants between 1 day and 50 days old due to cardiopulmonary events resulting from concurrent administration of IV cefTRIAXone and calcium-containing solutions; evidence of crystalline material or white precipitate in vascular beds was present in 4 of the infants 2. CefTRIAXone must not be mixed with or administered concurrently with calcium-containing IV solutions in the same administration line, including continuous calcium-containing infusions such as parenteral nutrition via a Y-site. In patients other than neonates, cefTRIAXone and calcium-containing solutions may be administered sequentially provided the infusion lines are thoroughly flushed between infusions with a compatible fluid 1.
Why it happens (mechanism)
Physical incompatibility
Literature reports
2 reports — tap to read
a) The reconstitution of cefTRIAXone sodium with diluents containing calcium such as Ringer's solution or Hartmann's solution can result in the formation of a cefTRIAXone-calcium precipitate. In newborns (term and premature), fatal reactions with cefTRIAXone-calcium precipitates in the lungs and kidneys have been reported following concomitant use of cefTRIAXone sodium and calcium-containing solutions or products, even via different administration lines and at different times. Similar reactions in patients other than neonates have not been reported. Additionally, no reports exist for an interaction between cefTRIAXone and oral calcium-containing products as well as between intramuscular cefTRIAXone and calcium-containing solutions (IV or oral) 1.
b) According to European postmarketing reports, 7 neonates (age range, 1 to 50 days; 5 preterm) experienced serious cardiopulmonary adverse events following concurrent administration of IV cefTRIAXone and calcium-containing solutions. CefTRIAXone dose ranged from 50 to 200 mg/kg/day, given as a single dose or divided every 12 hr, in 6 of the 7 infants; cefTRIAXone was administered by IV push in 3 infants. Coadministration with calcium-containing solutions occurred via same line or Y-site administration (n=4) or via different infusion lines (n=1). In 4 infants, cardiopulmonary events occurred within a few minutes to approximately 2 hr after administration of cefTRIAXone. Six of the 7 infants who received concurrent calcium gluconate died, while 1 infant who received calcium-containing hyperalimentation survived. Autopsy results from 4 of the 5 infants showed crystalline material or white precipitate in vascular beds, primarily in the lungs. Overall, factors contributing to an increased risk of death in these cases may have included higher than recommended cefTRIAXone doses (based on the United States Food and Drug Administration), IV push administration, and administering the total daily dose as a single infusion 2.
Common questions
Can I take Ringer's Solution and Ceftriaxone Injection together?
An increased risk of cefTRIAXone-calcium precipitates Always confirm with your pharmacist or prescriber before making any change.
How serious is the Ringer's Solution and Ceftriaxone Injection interaction?
It is rated contraindicated. These should generally not be used together.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
Questions for your pharmacist
- Does my dose of Ringer's Solution or Ceftriaxone Injection need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (2)
- Product Information: CEFTRIAXONE intravenous injection, ceftriaxone intravenous injection. Baxter Healthcare Corporation (per Dailymed), Deerfield, IL, 2024. DailyMed
- Bradley JS, Wassel RT, Lee L, et al: Intravenous ceftriaxone and calcium in the neonate: assessing the risk for cardiopulmonary adverse events. Pediatrics 2009; 123(4):e609-e613. PubMed
Keep reading about Ceftriaxone Injection
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist